Stroke Diagnostics - Global 麻豆原创 Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB512248763

Publication Date:

December 4, 2024

Pages:

130

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global market for Stroke Diagnostics was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Stroke Diagnostics, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Stroke Diagnostics by region & country, by Type, and by Application.
The Stroke Diagnostics market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Stroke Diagnostics.
麻豆原创 Segmentation
By Company
Abbott Laboratories Ltd.
Medtronic(Covidien)
General Electric Company(GE Healthcare)
Hitachi, Ltd.
Johnson & Johnson
Penumbra, Inc.
Koninklijke Philips N.V.
Siemens(Siemens International GmbH)
Stryker Corporation (Concentric Medical, Inc.)
Canon Medical Systems Corporation
Nihon Kohden Corporation
Sense Neuro Diagnostics
Forest Devices
Brainomix
Jan Medical
RapidAI
Viz.ai
Segment by Type:
Software
Hardware
Segment by Application
Ischemic Stroke
Hemorrhagic Stroke
Transient Ischemic Attack
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Stroke Diagnostics manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Stroke Diagnostics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Stroke Diagnostics in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 麻豆原创 Overview
1.1 Stroke Diagnostics Product Introduction
1.2 Global Stroke Diagnostics 麻豆原创 Size Forecast
1.3 Stroke Diagnostics 麻豆原创 Trends & Drivers
1.3.1 Stroke Diagnostics Industry Trends
1.3.2 Stroke Diagnostics 麻豆原创 Drivers & Opportunity
1.3.3 Stroke Diagnostics 麻豆原创 Challenges
1.3.4 Stroke Diagnostics 麻豆原创 Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Stroke Diagnostics Players Revenue Ranking (2023)
2.2 Global Stroke Diagnostics Revenue by Company (2019-2024)
2.3 Key Companies Stroke Diagnostics Manufacturing Base Distribution and Headquarters
2.4 Key Companies Stroke Diagnostics Product Offered
2.5 Key Companies Time to Begin Mass Production of Stroke Diagnostics
2.6 Stroke Diagnostics 麻豆原创 Competitive Analysis
2.6.1 Stroke Diagnostics 麻豆原创 Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Stroke Diagnostics Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Stroke Diagnostics as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Software
3.1.2 Hardware
3.2 Global Stroke Diagnostics Sales Value by Type
3.2.1 Global Stroke Diagnostics Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Stroke Diagnostics Sales Value, by Type (2019-2030)
3.2.3 Global Stroke Diagnostics Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Ischemic Stroke
4.1.2 Hemorrhagic Stroke
4.1.3 Transient Ischemic Attack
4.2 Global Stroke Diagnostics Sales Value by Application
4.2.1 Global Stroke Diagnostics Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Stroke Diagnostics Sales Value, by Application (2019-2030)
4.2.3 Global Stroke Diagnostics Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Stroke Diagnostics Sales Value by Region
5.1.1 Global Stroke Diagnostics Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Stroke Diagnostics Sales Value by Region (2019-2024)
5.1.3 Global Stroke Diagnostics Sales Value by Region (2025-2030)
5.1.4 Global Stroke Diagnostics Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Stroke Diagnostics Sales Value, 2019-2030
5.2.2 North America Stroke Diagnostics Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Stroke Diagnostics Sales Value, 2019-2030
5.3.2 Europe Stroke Diagnostics Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Stroke Diagnostics Sales Value, 2019-2030
5.4.2 Asia Pacific Stroke Diagnostics Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Stroke Diagnostics Sales Value, 2019-2030
5.5.2 South America Stroke Diagnostics Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Stroke Diagnostics Sales Value, 2019-2030
5.6.2 Middle East & Africa Stroke Diagnostics Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Stroke Diagnostics Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Stroke Diagnostics Sales Value
6.3 United States
6.3.1 United States Stroke Diagnostics Sales Value, 2019-2030
6.3.2 United States Stroke Diagnostics Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Stroke Diagnostics Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Stroke Diagnostics Sales Value, 2019-2030
6.4.2 Europe Stroke Diagnostics Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Stroke Diagnostics Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Stroke Diagnostics Sales Value, 2019-2030
6.5.2 China Stroke Diagnostics Sales Value by Type (%), 2023 VS 2030
6.5.3 China Stroke Diagnostics Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Stroke Diagnostics Sales Value, 2019-2030
6.6.2 Japan Stroke Diagnostics Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Stroke Diagnostics Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Stroke Diagnostics Sales Value, 2019-2030
6.7.2 South Korea Stroke Diagnostics Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Stroke Diagnostics Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Stroke Diagnostics Sales Value, 2019-2030
6.8.2 Southeast Asia Stroke Diagnostics Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Stroke Diagnostics Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Stroke Diagnostics Sales Value, 2019-2030
6.9.2 India Stroke Diagnostics Sales Value by Type (%), 2023 VS 2030
6.9.3 India Stroke Diagnostics Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Abbott Laboratories Ltd.
7.1.1 Abbott Laboratories Ltd. Profile
7.1.2 Abbott Laboratories Ltd. Main Business
7.1.3 Abbott Laboratories Ltd. Stroke Diagnostics Products, Services and Solutions
7.1.4 Abbott Laboratories Ltd. Stroke Diagnostics Revenue (US$ Million) & (2019-2024)
7.1.5 Abbott Laboratories Ltd. Recent Developments
7.2 Medtronic(Covidien)
7.2.1 Medtronic(Covidien) Profile
7.2.2 Medtronic(Covidien) Main Business
7.2.3 Medtronic(Covidien) Stroke Diagnostics Products, Services and Solutions
7.2.4 Medtronic(Covidien) Stroke Diagnostics Revenue (US$ Million) & (2019-2024)
7.2.5 Medtronic(Covidien) Recent Developments
7.3 General Electric Company(GE Healthcare)
7.3.1 General Electric Company(GE Healthcare) Profile
7.3.2 General Electric Company(GE Healthcare) Main Business
7.3.3 General Electric Company(GE Healthcare) Stroke Diagnostics Products, Services and Solutions
7.3.4 General Electric Company(GE Healthcare) Stroke Diagnostics Revenue (US$ Million) & (2019-2024)
7.3.5 Hitachi, Ltd. Recent Developments
7.4 Hitachi, Ltd.
7.4.1 Hitachi, Ltd. Profile
7.4.2 Hitachi, Ltd. Main Business
7.4.3 Hitachi, Ltd. Stroke Diagnostics Products, Services and Solutions
7.4.4 Hitachi, Ltd. Stroke Diagnostics Revenue (US$ Million) & (2019-2024)
7.4.5 Hitachi, Ltd. Recent Developments
7.5 Johnson & Johnson
7.5.1 Johnson & Johnson Profile
7.5.2 Johnson & Johnson Main Business
7.5.3 Johnson & Johnson Stroke Diagnostics Products, Services and Solutions
7.5.4 Johnson & Johnson Stroke Diagnostics Revenue (US$ Million) & (2019-2024)
7.5.5 Johnson & Johnson Recent Developments
7.6 Penumbra, Inc.
7.6.1 Penumbra, Inc. Profile
7.6.2 Penumbra, Inc. Main Business
7.6.3 Penumbra, Inc. Stroke Diagnostics Products, Services and Solutions
7.6.4 Penumbra, Inc. Stroke Diagnostics Revenue (US$ Million) & (2019-2024)
7.6.5 Penumbra, Inc. Recent Developments
7.7 Koninklijke Philips N.V.
7.7.1 Koninklijke Philips N.V. Profile
7.7.2 Koninklijke Philips N.V. Main Business
7.7.3 Koninklijke Philips N.V. Stroke Diagnostics Products, Services and Solutions
7.7.4 Koninklijke Philips N.V. Stroke Diagnostics Revenue (US$ Million) & (2019-2024)
7.7.5 Koninklijke Philips N.V. Recent Developments
7.8 Siemens(Siemens International GmbH)
7.8.1 Siemens(Siemens International GmbH) Profile
7.8.2 Siemens(Siemens International GmbH) Main Business
7.8.3 Siemens(Siemens International GmbH) Stroke Diagnostics Products, Services and Solutions
7.8.4 Siemens(Siemens International GmbH) Stroke Diagnostics Revenue (US$ Million) & (2019-2024)
7.8.5 Siemens(Siemens International GmbH) Recent Developments
7.9 Stryker Corporation (Concentric Medical, Inc.)
7.9.1 Stryker Corporation (Concentric Medical, Inc.) Profile
7.9.2 Stryker Corporation (Concentric Medical, Inc.) Main Business
7.9.3 Stryker Corporation (Concentric Medical, Inc.) Stroke Diagnostics Products, Services and Solutions
7.9.4 Stryker Corporation (Concentric Medical, Inc.) Stroke Diagnostics Revenue (US$ Million) & (2019-2024)
7.9.5 Stryker Corporation (Concentric Medical, Inc.) Recent Developments
7.10 Canon Medical Systems Corporation
7.10.1 Canon Medical Systems Corporation Profile
7.10.2 Canon Medical Systems Corporation Main Business
7.10.3 Canon Medical Systems Corporation Stroke Diagnostics Products, Services and Solutions
7.10.4 Canon Medical Systems Corporation Stroke Diagnostics Revenue (US$ Million) & (2019-2024)
7.10.5 Canon Medical Systems Corporation Recent Developments
7.11 Nihon Kohden Corporation
7.11.1 Nihon Kohden Corporation Profile
7.11.2 Nihon Kohden Corporation Main Business
7.11.3 Nihon Kohden Corporation Stroke Diagnostics Products, Services and Solutions
7.11.4 Nihon Kohden Corporation Stroke Diagnostics Revenue (US$ Million) & (2019-2024)
7.11.5 Nihon Kohden Corporation Recent Developments
7.12 Sense Neuro Diagnostics
7.12.1 Sense Neuro Diagnostics Profile
7.12.2 Sense Neuro Diagnostics Main Business
7.12.3 Sense Neuro Diagnostics Stroke Diagnostics Products, Services and Solutions
7.12.4 Sense Neuro Diagnostics Stroke Diagnostics Revenue (US$ Million) & (2019-2024)
7.12.5 Sense Neuro Diagnostics Recent Developments
7.13 Forest Devices
7.13.1 Forest Devices Profile
7.13.2 Forest Devices Main Business
7.13.3 Forest Devices Stroke Diagnostics Products, Services and Solutions
7.13.4 Forest Devices Stroke Diagnostics Revenue (US$ Million) & (2019-2024)
7.13.5 Forest Devices Recent Developments
7.14 Brainomix
7.14.1 Brainomix Profile
7.14.2 Brainomix Main Business
7.14.3 Brainomix Stroke Diagnostics Products, Services and Solutions
7.14.4 Brainomix Stroke Diagnostics Revenue (US$ Million) & (2019-2024)
7.14.5 Brainomix Recent Developments
7.15 Jan Medical
7.15.1 Jan Medical Profile
7.15.2 Jan Medical Main Business
7.15.3 Jan Medical Stroke Diagnostics Products, Services and Solutions
7.15.4 Jan Medical Stroke Diagnostics Revenue (US$ Million) & (2019-2024)
7.15.5 Jan Medical Recent Developments
7.16 RapidAI
7.16.1 RapidAI Profile
7.16.2 RapidAI Main Business
7.16.3 RapidAI Stroke Diagnostics Products, Services and Solutions
7.16.4 RapidAI Stroke Diagnostics Revenue (US$ Million) & (2019-2024)
7.16.5 RapidAI Recent Developments
7.17 Viz.ai
7.17.1 Viz.ai Profile
7.17.2 Viz.ai Main Business
7.17.3 Viz.ai Stroke Diagnostics Products, Services and Solutions
7.17.4 Viz.ai Stroke Diagnostics Revenue (US$ Million) & (2019-2024)
7.17.5 Viz.ai Recent Developments
8 Industry Chain Analysis
8.1 Stroke Diagnostics Industrial Chain
8.2 Stroke Diagnostics Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Stroke Diagnostics Sales Model
8.5.2 Sales Channel
8.5.3 Stroke Diagnostics Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

Abbott Laboratories Ltd.
Medtronic(Covidien)
General Electric Company(GE Healthcare)
Hitachi, Ltd.
Johnson & Johnson
Penumbra, Inc.
Koninklijke Philips N.V.
Siemens(Siemens International GmbH)
Stryker Corporation (Concentric Medical, Inc.)
Canon Medical Systems Corporation
Nihon Kohden Corporation
Sense Neuro Diagnostics
Forest Devices
Brainomix
Jan Medical
RapidAI
Viz.ai

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.